BIOPTIMATE ApS: Financial statements 2018
CVR: 36051183
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 12,582 and a net result of DKK 12,986 compared with DKK -24,306 the year before. Equity in the 2018 report amounted to DKK 87,916. The solvency ratio was 82.7%.
- Gross Profit
- DKK 12,582
- Profit/Loss
- DKK 12,986
- Equity
- DKK 87,916
- Total Assets
- DKK 106,333
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 13 t. | 13 t. | 88 t. | - |
| 2017 | - | -20 t. | -24 t. | 75 t. | - |
| 2016 | - | -13 t. | 39 t. | 99 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BIOPTIMATE ApS has published its annual report for 2017. Gross profit came to DKK -19,801, and the net result was DKK -24,306.
About BIOPTIMATE ApS
BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2025, the company reported a gross profit of DKK -1,252,436 and a net result of DKK -1,858,649 compared with DKK -6,367,118 the year before. Equity in the 2025 report amounted to DKK -5,714,314.